Investing
Top Active Trader Alert Stocks (CYTX, EBAY, FFIV, FITB, MNKD)
Published:
Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Cytori Therapeutics (NASDAQ: CYTX), eBay Inc. (NASDAQ: EBAY), F5 Networks, Inc. (NASDAQ: FFIV), Fifth Third Bancorp (NASDAQ: FITB), and MannKind Corporation (NASDAQ: MNKD).
Cytori Therapeutics (NASDAQ: CYTX) up approximately 12% premarket to $6.20, relative to a 52-week range of $3.15-$9.50. The Pharmaceutical company recently received approval to begin a line of stem cell-based research in the Netherlands.
eBay Inc. (NASDAQ: EBAY) have gained nearly 3% premarket to $29.97, relative to a 52-week range of $19.06-$31.54. The company recently reported healthy 4Q earnings.
F5 Networks, Inc. (NASDAQ: FFIV) is down more than 20% premarket to $110, relative to a 52-week range of $47.11-$145.76. In its Q1 report, the company actually met analyst expectations, but traders were expecting a strong beat.
Fifth Third Bancorp (NASDAQ: FITB) is down 3% to $14.15, relative to a 52-week range of $10.64-$15.95. The recent fall in shares comes after the company reported its 4Q earnings.
MannKind Corporation (NASDAQ: MNKD) has lost 43% of its value this morning to $5.21, relative to a 52-week range of $4.76-$11.08.
-Michael B. Sauter
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.